top of page

INFANRIX IPV+HIB VACCINE

Product details

Registration number: SIN10988P

Classification: Prescription Only

Active ingredients:

  • DIPHTHERIA TOXOID (D)
  • FILAMENTOUS HAEMAGGLUTININ (FHA)
  • HIB PURIFIED CAPSULAR POLYSACCHARIDE
  • PERTACTIN (PRN or 69kDa Outer Membrane Protein)
  • PERTUSSIS TOXOID (PT)
  • POLIO VIRUS TYPE 1 (INACTIVATED)
  • POLIO VIRUS TYPE 2 (INACTIVATED)
  • POLIO VIRUS TYPE 3 (INACTIVATED)
  • TETANUS TOXOID (T)

Strength:

  • min 30IU/0.5ml
  • 25mcg/0.5ml
  • 10 mcg/0.5 ml
  • 8mcg/0.5ml
  • 25mcg/0.5ml
  • 40DU/0.5ml
  • 8DU/0.5ml
  • 32DU/0.5ml
  • min 40IU/0.5ml

Dosage form: INJECTION

Route: INTRAMUSCULAR

Registrant: GLAXOSMITHKLINE PTE LTD

ATC code: J07CA06

HSA approval date: 25 June 1999

Manufacturer(s):

  • GlaxoSmithKline Biologicals
  • GlaxoSmithKline Biologicals SA

Manufacturing country/countries: FRANCE; BELGIUM

What are the HSA registration number and classification for INFANRIX IPV+HIB VACCINE?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN10988P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for INFANRIX IPV+HIB VACCINE?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • DIPHTHERIA TOXOID (D)
  • FILAMENTOUS HAEMAGGLUTININ (FHA)
  • HIB PURIFIED CAPSULAR POLYSACCHARIDE
  • PERTACTIN (PRN or 69kDa Outer Membrane Protein)
  • PERTUSSIS TOXOID (PT)
  • POLIO VIRUS TYPE 1 (INACTIVATED)
  • POLIO VIRUS TYPE 2 (INACTIVATED)
  • POLIO VIRUS TYPE 3 (INACTIVATED)
  • TETANUS TOXOID (T)

Strength:

  • min 30IU/0.5ml
  • 25mcg/0.5ml
  • 10 mcg/0.5 ml
  • 8mcg/0.5ml
  • 25mcg/0.5ml
  • 40DU/0.5ml
  • 8DU/0.5ml
  • 32DU/0.5ml
  • min 40IU/0.5ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for INFANRIX IPV+HIB VACCINE?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for INFANRIX IPV+HIB VACCINE?

According to the HSA dataset updated 7 August 2026:

Registrant: GLAXOSMITHKLINE PTE LTD

Source for this answer

Which manufacturers and countries are listed for INFANRIX IPV+HIB VACCINE?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • GlaxoSmithKline Biologicals
  • GlaxoSmithKline Biologicals SA

Manufacturing country/countries: FRANCE; BELGIUM

Source for this answer

Where can I look up INFANRIX IPV+HIB VACCINE in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN10988P or the exact product name INFANRIX IPV+HIB VACCINE. The general register link does not preselect this product.

Source for this answer

What are the source dates for this INFANRIX IPV+HIB VACCINE record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this INFANRIX IPV+HIB VACCINE record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN10988P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page